Article Information
vol. 12 no. 556
- Received for publication July 17, 2019
- Resubmitted February 21, 2020
- Accepted for publication June 5, 2020
- .
Author Information
- Laurent Calvier1,2,*,
- Guillaume Demuth1,2,
- Navid Manouchehri3,
- Connie Wong1,2,
- Anastasia Sacharidou4,
- Chieko Mineo4,
- Philip W. Shaul4,
- Nancy L. Monson3,
- Maria Z. Kounnas5,
- Olaf Stüve3,6 and
- Joachim Herz1,2,3,7,*
- 1Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 2Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 3Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 4Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 5Reelin Therapeutics Inc. La Jolla, CA 92037, USA.
- 6Department of Neurology, VA North Texas Health Care System, Medical Service, Dallas, TX 75390, USA.
- 7Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- ↵*Corresponding author. Email: calvier.laurent{at}gmail.com (L.C.); joachim.herz{at}utsouthwestern.edu (J.H.)